Lake Street Capital Markets Analyst, Ryan Meyers, initiated coverage of PetMed Express, Inc. with a BUY rating and price target of $20 (PETS-$20). PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.